The U.S. Department of Defense has awarded a substantial grant of $11.9 million to the Oregon State University (OSU) College of Pharmacy, with the aim of developing advanced drug delivery technologies specifically designed to protect military personnel from various health threats encountered in
Adicet Bio is pioneering significant developments in its innovative CAR T-cell therapy, ADI-001, aimed at treating a range of autoimmune diseases. Among the targeted conditions are ANCA-associated vasculitis (AAV), systemic lupus erythematosus (SLE), and systemic sclerosis. Initially, patient
The contract development and manufacturing organization (CDMO) industry has seen significant advancements and partnerships as of January 2025. With a focus on large molecules and advanced therapies, this article delves into the latest developments, highlighting key trends, common themes, and
The Illinois Department of Healthcare and Family Services (HFS) has taken a significant step toward improving treatment access and affordability for Sickle Cell Disease (SCD) patients by issuing its first comprehensive report on gene and cell therapy treatments. This report, generated in
Artificial intelligence (AI) is revolutionizing various sectors, and medicine is no exception. Researchers at UC San Francisco (UCSF) are at the forefront of integrating AI and machine learning with medical imaging to create human-centered AI solutions. These innovations aim to tackle some of the
The groundbreaking study conducted by researchers Yang Zhang, PhD, and Jinjun Shi, PhD, from Brigham and Women's Hospital, offers promising insights into the potential of RNA nanoparticles in treating advanced prostate cancer (PCa). Their research focuses on a dual-action strategy involving
The Blood and Cell Advocacy Register (BCAR) is a newly launched consortium that aims to revolutionize the development and commercialization of advanced therapy medicinal products (ATMPs). Formed in December 2024, BCAR brings together experts and organizations from the blood and cell industries to
The fight against advanced prostate cancer has taken a promising turn with the development of a new drug, NXP800. This innovative treatment aims to help patients for whom current therapies have become ineffective. By specifically targeting the heat shock factor 1 (HSF1) pathway, NXP800 addresses
The intricate relationship between socioeconomic development and the global cancer burden is a critical area of study that warrants thorough exploration. Utilizing data from the GLOBOCAN 2020 report, this article delves into the disparities in cancer incidence, mortality, and healthcare outcomes
Randomized controlled trials (RCTs) are widely recognized as the gold standard for evaluating the efficacy of interventions. In the context of HIV research in Africa, multicenter RCTs are particularly valuable due to the diverse socio-cultural and geographical settings. This scoping review aims to
